|
Pons-Fuster E, Lozano-Caballero O, Martin-Balbuena S, Lucas-Rodenas C, Mancebo-Gonzalez A, De Gorostiza-Frias I, Gonzalez-Ponce CM. Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. Int J Clin Pharm. 2024 Dec;46(6):1317-1326. doi: 10.1007/s11096-024-01758-2. Epub 2024 Jul 11. PubMed PMID: 38990457.
AÑO: 2024; IF: 2.6
|
38990457